Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis.

Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis.

<h4>Background</h4>Aberrant brain insulin signaling has been posited to lie at the crossroads of several metabolic and cognitive disorders. Intranasal insulin (INI) is a non-invasive approach that allows investigation and modulation of insulin signaling in the brain while limiting periph...

Full description

Bibliographic Details
Main Authors:	Sally Wu, Nicolette Stogios, Margaret Hahn, Janani Navagnanavel, Zahra Emami, Araba Chintoh, Philip Gerretsen, Ariel Graff-Guerrero, Tarek K Rajji, Gary Remington, Sri Mahavir Agarwal
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0286887

Similar Items

Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health
by: Nicolette Stogios, et al.
Published: (2021-04-01)

Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls.
by: Nicolette Stogios, et al.
Published: (2022-01-01)

Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls
by: Nicolette Stogios, et al.
Published: (2022-01-01)

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
by: Nicole E. MacKenzie, et al.
Published: (2018-12-01)

Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
by: Raghunath Singh, et al.
Published: (2022-05-01)

Metabolomic signatures associated with weight gain and psychosis spectrum diagnoses: A pilot study
by: Jiwon Lee, et al.
Published: (2023-04-01)

Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia
by: Kenya A. Costa-Dookhan, et al.
Published: (2021-01-01)

Exploring Patterns of Disturbed Eating in Psychosis: A Scoping Review
by: Nicolette Stogios, et al.
Published: (2020-12-01)

Non-invasive neuromodulation of dorsolateral prefrontal cortex to reduce craving in alcohol use disorder: A meta-analysis
by: Maryam Sorkhou, et al.
Published: (2022-09-01)

Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series
by: Femin Prasad, et al.
Published: (2023-04-01)

Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial
by: Sri Mahavir Agarwal, et al.
Published: (2021-04-01)

The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment
by: Alex T. Raben, et al.
Published: (2018-01-01)

Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis
by: Pruntha Kanagasundaram, et al.
Published: (2021-03-01)

Intranasal insulin neuroprotection in ischemic stroke
by: Vasileios-Arsenios Lioutas, et al.
Published: (2016-01-01)

Editorial: Cardiovascular and Physical Health in Severe Mental Illness
by: Sri Mahavir Agarwal, et al.
Published: (2021-09-01)

The hidden obstacles to intranasal insulin delivery: A narrative review
by: Ujjawal Rawat, et al.
Published: (2023-01-01)

Odor Sensitivity After Intranasal Insulin Application Is Modulated by Gender
by: Rea Rodriguez-Raecke, et al.
Published: (2018-10-01)

Rapid transport of insulin to the brain following intranasal administration in rats
by: Lir-Wan Fan, et al.
Published: (2019-01-01)

Effect of intranasal insulin on peripheral glucose profile in dexamethasone-induced insulin resistance in Wistar rats
by: Anoka A. Njan, et al.
Published: (2018-12-01)

Synthesis of a Rivastigmine and Insulin Combinational Mucoadhesive Nanoparticle for Intranasal Delivery
by: Tahereh Jamshidnejad-Tosaramandani, et al.
Published: (2024-02-01)

Manganese‐induced parkinsonism responsive to intranasal insulin: A case report
by: Mehri Salari, et al.
Published: (2022-03-01)

Intranasal insulin ameliorates neurological impairment after intracerebral hemorrhage in mice
by: Yuan Zhu, et al.
Published: (2022-01-01)

Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol
by: Sri Mahavir Agarwal, et al.
Published: (2023-01-01)

Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol.
by: Sri Mahavir Agarwal, et al.
Published: (2023-01-01)

Intranasal Insulin Prevents Anesthesia-Induced Cognitive Impairment and Chronic Neurobehavioral Changes
by: Yanxing Chen, et al.
Published: (2017-05-01)

Intranasal insulin affects adenyl cyclase system in rat tissues in neonatal diabetes
by: Shpakov Alexander, et al.
Published: (2012-02-01)

Intranasal insulin reverts central pathology and cognitive impairment in diabetic mother offspring
by: Juan Jose Ramos-Rodriguez, et al.
Published: (2017-08-01)

Can Intranasal Insulin and Cholinergic Agonist Improve Post-Covid-19 Cognition Impairment?
by: Amr Ahmed, et al.
Published: (2024-03-01)

Metabolic and Cognitive Outcomes of Subchronic Once-Daily Intranasal Insulin Administration in Healthy Men
by: Yvonne Ritze, et al.
Published: (2018-11-01)

Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin
by: Toshihiko Tashima
Published: (2020-11-01)

Synthesis of an insulin-loaded mucoadhesive nanoparticle designed for intranasal administration: focus on new diffusion media
by: Tahereh Jamshidnejad-Tosaramandani, et al.
Published: (2023-08-01)

Intranasal insulin prevents anesthesia-induced hyperphosphorylation of tau in 3xTg-AD mice
by: Yanxing eChen, et al.
Published: (2014-05-01)

Intranasal insulin: the effects of three dose regimens on postprandial glycaemic profiles in type II diabetic subjects
by: Ismail, I.S., et al.
Published: (1995)

Protective Effect of Intranasal Insulin Administration on Cognitive Functions and Neurogenesis in a Rat Model of Alzheimer\'s Disease
by: Z Eshrati, et al.
Published: (2023-03-01)

Intranasal insulin enhances brain functional connectivity mediating the relationship between adiposity and subjective feeling of hunger
by: Stephanie Kullmann, et al.
Published: (2017-05-01)

Determinants of social distancing adherence
by: Philip Gerretsen, et al.
Published: (2023-01-01)

Vaccine Hesitancy Is a Barrier to Achieving Equitable Herd Immunity Among Racial Minorities
by: Philip Gerretsen, et al.
Published: (2021-11-01)

Intranasal dexmedetomidine and intranasal ketamine association allows shorter induction time for pediatric sedation compared to intranasal dexmedetomidine and oral midazolam
by: Francesca Cossovel, et al.
Published: (2022-01-01)

Integrated transcriptome and metabolome analysis to investigate the mechanism of intranasal insulin treatment in a rat model of vascular dementia
by: Liang Tang, et al.
Published: (2023-05-01)

Efficacy of intranasal insulin in improving cognition in mild cognitive impairment or dementia: a systematic review and meta-analysis
by: Cong Long, et al.
Published: (2022-09-01)